You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

β2 Adrenergic receptor

Showing 1 - 25 of 8,587
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial in Spain (To compare in both treatment arms the percentage of patients controlled at week 52.)

Recruiting
  • Asthma
  • To compare in both treatment arms the percentage of patients controlled at week 52.
  • Inca, Baleares, Spain
  • +16 more
Jun 16, 2023

Repeat Immunoadsorption Post Covid ME/CFS

Recruiting
  • Post-COVID ME/CFS
  • IA with TheraSorb ® column
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin
Nov 21, 2022

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li，MD
Apr 18, 2023

Type 2 Diabetes, Obesity Trial in Sherbrooke (drug, other, diagnostic test, procedure)

Recruiting
  • Type 2 Diabetes
  • Obesity
  • Formoterol Fumarate 12 micrograms Inhalation Powder
  • +8 more
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Sep 22, 2022

Acute Asthma Responsiveness and B2 Adrenergic Receptors

Completed
  • Acute Asthma
    • Cleveland, Ohio
      MetroHealth Medical Center
    Aug 26, 2021

    Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

    Recruiting
    • Fanconi Anemia
    • +2 more
    • Total Body Irradiation (TBI) (Plan 1)
    • +8 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Nov 2, 2022

    Nonalcoholic Steatohepatitis (NASH) Trial (ASC41 2 mg, ASC41 4 mg, Placebo)

    Not yet recruiting
    • Nonalcoholic Steatohepatitis (NASH)
    • ASC41 2 mg
    • +2 more
    • (no location specified)
    Jan 30, 2023

    Children With Bronchiolitis

    Active, not recruiting
    • Bronchiolitis
      • Hartford, Connecticut
        Connecticut Children's Medical Center
      Jul 8, 2021

      Healthy Volunteers Trial in New York (Clonidine Pill)

      Withdrawn
      • Healthy Volunteers
      • Clonidine Pill
      • New York, New York
        Weill Cornell Medicine
      Jul 14, 2021

      Acute Respiratory Distress Syndrome Trial (Esmolol)

      Not yet recruiting
      • Acute Respiratory Distress Syndrome
      • (no location specified)
      Aug 22, 2023

      Delirium, Cognitive Decline, Frailty Trial in Bergen, Oslo, Trondheim (Dexmedetomidine, Clonidine, Natriumchlorid)

      Recruiting
      • Delirium
      • +2 more
      • Bergen, Norway
      • +3 more
      Apr 25, 2022

      Sympathetic Transduction in Obesity

      Not yet recruiting
      • Hypertension
      • No intervention
      • (no location specified)
      Oct 18, 2022

      ß1-adrenergic Antagonists on Nociceptive-Level Index Variation

      Completed
      • Nociception During Anesthesia in Patients Taking β1-adrenergic Antagonist Chronic Treatment
      • standardized noxious stimulus under general anesthesia.
      • Montréal-Est, Quebec, Canada
        Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montre
      Aug 31, 2020

      Type1diabetes, Hypoglycemia, Hypoglycemia Unawareness Trial in Philadelphia (Phentolamine, Propranolol, Placebo)

      Active, not recruiting
      • Type1diabetes
      • +3 more
      • Philadelphia, Pennsylvania
        University of Pennsylvania - Institute for Diabetes, Obesity and
      Mar 3, 2022

      Cardiomyopathy, Dilated, Heart Failure, Autoantibodies Trial in Belgrade, Belgrad (BC 007)

      Active, not recruiting
      • Cardiomyopathy, Dilated
      • +2 more
      • BC 007
      • Belgrade, Serbia
      • +2 more
      Jul 19, 2022

      Non-Hodgkin's Lymphoma Trial in Stanford ([ 18F]F-AraG PET)

      Recruiting
      • Non-Hodgkin's Lymphoma
      • [ 18F]F-AraG PET
      • Stanford, California
        Stanford University, School of Medicine
      Oct 14, 2021

      POTS Adrenergic Ab (CIHR Aims #1&2)

      Recruiting
      • Postural Tachycardia Syndrome
      • Calgary, Alberta, Canada
        University of Calgary
      Feb 4, 2022

      Asthma Trial in Worldwide (Rilzabrutinib, )

      Recruiting
      • Asthma
      • Berazategui, Buenos Aires, Argentina
      • +24 more
      Dec 29, 2022

      Puerto Rican Children With Asthma

      Completed
      • Asthma in Children
      • Inhaled corticosteroid (mometasone)
      • Pittsburgh, Pennsylvania
      • +1 more
      Jul 6, 2022

      Hypertrophy, Left Ventricular Trial in Worldwide (drug, procedure, radiation)

      Active, not recruiting
      • Hypertrophy, Left Ventricular
      • Brussels, Belgium
      • +8 more
      Sep 28, 2021

      Aging Trial in Hershey (Angiotensin-(1-7), Saline)

      Not yet recruiting
      • Aging
      • Hershey, Pennsylvania
        Penn State Milton S. Hershey Medical Center
      Jul 12, 2022

      Obesity, Vasodilation, Healthy Trial in Columbia (Propranolol Hydrochloride, Isoproterenol, Acetylcholine)

      Not yet recruiting
      • Obesity
      • +2 more
      • Propranolol Hydrochloride
      • +4 more
      • Columbia, Missouri
        University of Missouri
      Nov 11, 2022

      Advanced Melanoma Trial in New Brunswick (Propranolol, Naltrexone)

      Not yet recruiting
      • Advanced Melanoma
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      Jul 18, 2023

      Vasoconstriction, Vasodilation Trial in Edmonton (Phenylephrine Hydrochloride, Isoproterenol Hydrochloride, Norepinephrine

      Not yet recruiting
      • Vasoconstriction
      • Vasodilation
      • Phenylephrine Hydrochloride
      • +4 more
      • Edmonton, Alberta, Canada
        University of Alberta
      Aug 21, 2023

      Post-COVID-19 Syndrome, Post-COVID Syndrome, Post COVID-19 Condition Trial in Mainz (Immunoadsorption, Sham-apheresis)

      Recruiting
      • Post-COVID-19 Syndrome
      • +2 more
      • Immunoadsorption
      • Sham-apheresis
      • Mainz, Rheinland-Pfalz, Germany
        UNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz I.
      May 2, 2023